PERGOLIDE IN THE TREATMENT OF PARKINSONS-DISEASE

被引：27

作者：

MEAR, JY

BARROCHE, G

DESMET, Y

WEBER, M

LHERMITTE, F

AGID, Y

机构：

[1] CLIN NEUROL & NEUROPSYCHOL,PARIS,FRANCE

[2] CLIN NEUROL,NANCY,FRANCE

来源：

NEUROLOGY | 1984年 / 34卷 / 07期

关键词：

D O I：

10.1212/WNL.34.7.983

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：983 / 986

页数：4

共 19 条

[1] BROMOCRIPTINE ASSOCIATED WITH A PERIPHERAL DOPAMINE BLOCKING-AGENT IN TREATMENT OF PARKINSONS-DISEASE [J].

AGID, Y ;

BONNET, AM ;

POLLAK, P ;

SIGNORET, JL ;

LHERMITTE, F .

LANCET, 1979, 1 (8116) :570-572

[2]

AGID Y, 1979, BIOMEDICINE, V30, P67

[3]

FAHN S, 1979, ADV NEUROL, V24, P451

[4] INTERACTION OF PERGOLIDE WITH CENTRAL DOPAMINERGIC RECEPTORS [J].

GOLDSTEIN, M ;

LIEBERMAN, A ;

LEW, JY ;

ASANO, T ;

ROSENFELD, MR ;

MAKMAN, MH .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (06) :3725-3728

[5] PARKINSONISM - ONSET PROGRESSION AND MORTALITY [J].

HOEHN, MM ;

YAHR, MD .

NEUROLOGY, 1967, 17 (05) :427-&

[6] STIMULANT PROPERTIES OF BROMOCRIPTINE ON CENTRAL DOPAMINE RECEPTORS IN COMPARISON TO APOMORPHINE, (+)-AMPHETAMINE AND L-DOPA [J].

JOHNSON, AM ;

LOEW, DM ;

VIGOURET, JM .

BRITISH JOURNAL OF PHARMACOLOGY, 1976, 56 (01) :59-68

[7] DOMPERIDONE, A SPECIFIC INVITRO DOPAMINE ANTAGONIST, DEVOID OF INVIVO CENTRAL DOPAMINERGIC ACTIVITY [J].

LADURON, PM ;

LEYSEN, JE .

BIOCHEMICAL PHARMACOLOGY, 1979, 28 (14) :2161-2165

[8] RECEPTOR BASIS FOR DOPAMINERGIC SUPER-SENSITIVITY IN PARKINSONS-DISEASE [J].

LEE, T ;

SEEMAN, P ;

RAJPUT, A ;

FARLEY, IJ ;

HORNYKIEWICZ, O .

NATURE, 1978, 273 (5657) :59-61

[9]

LEES AJ, 1981, LANCET, V2, P577

[10] PHARMACOLOGIC EFFECTS IN MAN OF A POTENT, LONG-ACTING DOPAMINE RECEPTOR AGONIST [J].

LEMBERGER, L ;

CRABTREE, RE .

SCIENCE, 1979, 205 (4411) :1151-1153

← 1 2 →